Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906
Public ClinicalTrials.gov record NCT04717934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Main Study: A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Sub-study to Assess Interpretation of Mammograms Following Treatment for Correction of Wrinkles in the Décolletage Area in the Investigational Study 43USRV1906
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Main study: Randomized, evaluator-blinded, no treatment controlled multicenter study to evaluate safety and effectiveness of GAL1906 for the correction of wrinkles in the décolletage area. Sub-study: To evaluate imaging interpretation of mammograms in subjects who were enrolled and treated in the 43USRV1906 main study. The sub-study will determine if hyaluronic acid injections in the décolletage interfere with diagnosis or interpretation of mammogram results.
Study identification
- NCT ID
- NCT04717934
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 211 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 7, 2021
- Primary completion
- May 25, 2025
- Completion
- Jun 12, 2025
- Last update posted
- Jul 14, 2026
2021 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Research Site | Birmingham | Alabama | 35209 | — |
| Galderma Research Site | Scottsdale | Arizona | 85255 | — |
| Galderma Research Site | Redondo Beach | California | 90277 | — |
| Galderma Research Site | San Diego | California | 92121 | — |
| Galderma Research Site | Vista | California | 92083 | — |
| Galderma Research Site | Westport | Connecticut | 06880 | — |
| Galderma Research Site | Boynton Beach | Florida | 33472 | — |
| Galderma Research Site | Coral Gables | Florida | 33146 | — |
| Galderma Research Site | Alpharetta | Georgia | 30022 | — |
| Galderma Research Site | Chicago | Illinois | 60654 | — |
| Galderma Research Site | Baltimore | Maryland | 21208 | — |
| Galderma Research Site | New York | New York | 10021 | — |
| Galderma Research Site | Spring | Texas | 77388 | — |
| Galderma Research Site | Mequon | Wisconsin | 53092 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04717934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 14, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04717934 live on ClinicalTrials.gov.